These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38048279)

  • 21. Short article: Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study.
    Sellier PO; Schnepf N; Amarsy R; Maylin S; Lopes A; Mazeron MC; Flateau C; Morgand M; Ciraru-Vigneron N; Berthe A; Simoneau G; Evans J; Souak S; Matheron S; Benifla JL; Simon F; Bergmann JF
    Eur J Gastroenterol Hepatol; 2016 Mar; 28(3):328-32. PubMed ID: 26709883
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection.
    Celen MK; Mert D; Ay M; Dal T; Kaya S; Yildirim N; Gulsun S; Barcin T; Kalkanli S; Dal MS; Ayaz C
    World J Gastroenterol; 2013 Dec; 19(48):9377-82. PubMed ID: 24409065
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacological interventions for acute hepatitis B infection: an attempted network meta-analysis.
    Mantzoukis K; Rodríguez-Perálvarez M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011645. PubMed ID: 28321877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection.
    Han GR; Cao MK; Zhao W; Jiang HX; Wang CM; Bai SF; Yue X; Wang GJ; Tang X; Fang ZX
    J Hepatol; 2011 Dec; 55(6):1215-21. PubMed ID: 21703206
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of antiviral therapy in reducing perinatal transmission of hepatitis B virus and maternal outcomes after discontinuing them.
    Seo KI; Bae SH; Sung PS; Park CH; Lee HL; Kim HY; Kim HJ; Jang BH; Jang JW; Yoon SK; Choi JY; Park IY; Lee J; Lee HS; Kim SJ; Kwon JH; Chang UI; Kim CW; Jo SH; Lee Y; Tekle F; Kim JH
    Clin Mol Hepatol; 2018 Dec; 24(4):374-383. PubMed ID: 29940720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of lamivudine treatment in late pregnancy with high HBV DNA: a perspective for mother and infants.
    Köse S; Türken M; Devrim I; Taner C
    J Infect Dev Ctries; 2011 Apr; 5(4):303-6. PubMed ID: 21537073
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations.
    Ayres A; Yuen L; Jackson KM; Manoharan S; Glass A; Maley M; Yoo W; Hong SP; Kim SO; Luciani F; Bowden DS; Bayliss J; Levy MT; Locarnini SA
    J Viral Hepat; 2014 Nov; 21(11):809-17. PubMed ID: 24329944
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of telbivudine to prevent mother-to-child transmission of hepatitis B virus in middle- and late-stage pregnancy with high viral loads.
    Xu J; Tao LL; Ma LX
    J Med Virol; 2019 Dec; 91(12):2153-2157. PubMed ID: 31397488
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of Nucleotide/Nucleoside Analogues and Hepatitis B Immunoglobulin Therapy in Blocking Mother-to-Child Transmission of Hepatitis B in an Eastern Chinese Group.
    Sun X; Wang C; Wang B; Yang X; Xu H; Shen M; Zhu K
    Infect Dis Obstet Gynecol; 2020; 2020():4305950. PubMed ID: 33380780
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Safety and efficacy of telbivudine in late pregnancy to prevent mother-to-child transmission of hepatitis B virus: A multicenter prospective cohort study.
    Hu Y; Xu C; Xu B; Hu L; Liu Q; Chen J; Liu J; Liu L; Yang J; Chen T; Wen J; Jiang N; Zhang Y; Cao M; Feng J; Lin X; Wang Z; Xu B; Zhou YH
    J Viral Hepat; 2018 Apr; 25(4):429-437. PubMed ID: 29193547
    [TBL] [Abstract][Full Text] [Related]  

  • 31. #38: Hepatitis B in pregnancy screening, treatment, and prevention of vertical transmission.
    ; Dionne-Odom J; Tita AT; Silverman NS
    Am J Obstet Gynecol; 2016 Jan; 214(1):6-14. PubMed ID: 26454123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of tenofovir or telbivudine in preventing HBV vertical transmission for pregnancy.
    Zeng J; Zheng C; Li H
    Medicine (Baltimore); 2019 Apr; 98(14):e15092. PubMed ID: 30946367
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of the efficacy and safety of tenofovir and telbivudine in interrupting mother-to-child transmission of hepatitis B virus.
    Zhu B; Lv X; Zhao Z; Chen L; Chen X; Li C; Li S; Dai E
    Medicine (Baltimore); 2021 Nov; 100(44):e27695. PubMed ID: 34871254
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Decreased neonatal hepatitis B virus (HBV) viremia by maternal tenofovir treatment predicts reduced chronic HBV infection in children born to highly viremic mothers.
    Chang KC; Chang MH; Lee CN; Chang CH; Wu JF; Ni YH; Wen WH; Shyu MK; Lai MW; Chen SM; Hu JJ; Lin HH; Hsu JJ; Mu SC; Lin YC; Liu CJ; Chen DS; Lin LH; Chen HL;
    Aliment Pharmacol Ther; 2019 Aug; 50(3):306-316. PubMed ID: 31271463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Safety and efficacy of lamivudine or telbivudine started in early pregnancy for mothers with active chronic hepatitis B.
    He T; Bai Y; Cai H; Ou X; Liu M; Yi W; Jia J
    Hepatol Int; 2018 Mar; 12(2):118-125. PubMed ID: 29344772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tenofovir versus Placebo to Prevent Perinatal Transmission of Hepatitis B.
    Jourdain G; Ngo-Giang-Huong N; Harrison L; Decker L; Khamduang W; Tierney C; Salvadori N; Cressey TR; Sirirungsi W; Achalapong J; Yuthavisuthi P; Kanjanavikai P; Na Ayudhaya OP; Siriwachirachai T; Prommas S; Sabsanong P; Limtrakul A; Varadisai S; Putiyanun C; Suriyachai P; Liampongsabuddhi P; Sangsawang S; Matanasarawut W; Buranabanjasatean S; Puernngooluerm P; Bowonwatanuwong C; Puthanakit T; Klinbuayaem V; Thongsawat S; Thanprasertsuk S; Siberry GK; Watts DH; Chakhtoura N; Murphy TV; Nelson NP; Chung RT; Pol S; Chotivanich N
    N Engl J Med; 2018 Mar; 378(10):911-923. PubMed ID: 29514030
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Efficacy and safety of telbivudine treatment to block mother-to-child transmission of hepatitis B virus: a meta-analysis].
    Xu HX; Wang LJ; Yu YX; Wu YP; Xu YF; Liu XX; Chen Y
    Zhonghua Gan Zang Bing Za Zhi; 2012 Oct; 20(10):755-60. PubMed ID: 23207336
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of the Efficacy and Safety of Tenofovir Disoproxil Fumarate in Intercepting Mother-to-Child Transmission of Hepatitis B Virus.
    Han D; Du J; Wang W; Wang C
    Acta Med Okayama; 2024 Apr; 78(2):107-113. PubMed ID: 38688828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa.
    Mokaya J; Burn EAO; Tamandjou CR; Goedhals D; Barnes EJ; Andersson M; Pinedo-Villanueva R; Matthews PC
    BMC Public Health; 2019 Jun; 19(1):829. PubMed ID: 31242901
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative efficacy of antiviral therapy in preventing vertical transmission of hepatitis B: a network meta-analysis.
    Njei B; Gupta N; Ewelukwa O; Ditah I; Foma M; Lim JK
    Liver Int; 2016 May; 36(5):634-41. PubMed ID: 26352650
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.